DK1186607T3 - Optisk aktive pyrrolopyridazinforbindelser - Google Patents

Optisk aktive pyrrolopyridazinforbindelser

Info

Publication number
DK1186607T3
DK1186607T3 DK00939072T DK00939072T DK1186607T3 DK 1186607 T3 DK1186607 T3 DK 1186607T3 DK 00939072 T DK00939072 T DK 00939072T DK 00939072 T DK00939072 T DK 00939072T DK 1186607 T3 DK1186607 T3 DK 1186607T3
Authority
DK
Denmark
Prior art keywords
optically active
pharmaceutically acceptable
alkyl
active pyrrolopyridazine
activity
Prior art date
Application number
DK00939072T
Other languages
Danish (da)
English (en)
Inventor
M Hagihara
N Shibakawa
K Matsunobu
H Fujiwara
Keiichi Ito
Original Assignee
Sankyo Co
Ube Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co, Ube Industries filed Critical Sankyo Co
Application granted granted Critical
Publication of DK1186607T3 publication Critical patent/DK1186607T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK00939072T 1999-06-15 2000-06-15 Optisk aktive pyrrolopyridazinforbindelser DK1186607T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP16767999 1999-06-15
PCT/JP2000/003895 WO2000077003A1 (en) 1999-06-15 2000-06-15 Optically active pyrrolopyridazine compounds

Publications (1)

Publication Number Publication Date
DK1186607T3 true DK1186607T3 (da) 2003-09-01

Family

ID=15854223

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00939072T DK1186607T3 (da) 1999-06-15 2000-06-15 Optisk aktive pyrrolopyridazinforbindelser

Country Status (25)

Country Link
US (1) US6670360B2 (cs)
EP (1) EP1186607B1 (cs)
KR (1) KR100583663B1 (cs)
CN (1) CN1170829C (cs)
AT (1) ATE240957T1 (cs)
AU (1) AU757611B2 (cs)
BR (1) BR0011666A (cs)
CA (1) CA2375848A1 (cs)
CZ (1) CZ290935B6 (cs)
DE (1) DE60002860T2 (cs)
DK (1) DK1186607T3 (cs)
ES (1) ES2198319T3 (cs)
HK (1) HK1044341B (cs)
HU (1) HUP0201434A3 (cs)
IL (2) IL147088A0 (cs)
MX (1) MXPA01013011A (cs)
NO (1) NO20016099L (cs)
NZ (1) NZ516194A (cs)
PL (1) PL356479A1 (cs)
PT (1) PT1186607E (cs)
RU (1) RU2222541C2 (cs)
TR (1) TR200103685T2 (cs)
TW (1) TWI287014B (cs)
WO (1) WO2000077003A1 (cs)
ZA (1) ZA200110279B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100750551B1 (ko) * 2000-02-10 2007-08-20 상꾜 가부시키가이샤 피롤로피리다진 화합물
AU2003266622A1 (en) * 2002-09-25 2004-04-19 Sankyo Company, Limited Medicinal composition for inhibiting increase in blood gastrin concentration
TW200418479A (en) * 2002-09-25 2004-10-01 Sankyo Co Pharmaceutical compositions for the treatment or prevention of visceral pains
EP1974730A1 (en) 2003-11-03 2008-10-01 AstraZeneca AB Imidazo[1,2-a]pyridine derivatives for use in the treatment of sleep disturbance due to silent gastro-esophageal reflux
KR100958828B1 (ko) * 2004-09-03 2010-05-24 주식회사유한양행 피롤로[3,2-b]피리딘 유도체 및 그의 제조방법
CN101003537A (zh) * 2006-01-17 2007-07-25 上海恒瑞医药有限公司 吡咯并哒嗪类衍生物及其制备方法和用途
CN105919998B (zh) 2009-07-09 2021-08-24 拉夸里亚创药株式会社 用于治疗与异常肠胃运动有关的疾病的酸泵拮抗剂
CN105367550A (zh) * 2014-08-11 2016-03-02 江苏柯菲平医药股份有限公司 四氢环戊二烯并[c]吡咯类衍生物、其制备方法及其在医药上的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL97931A0 (en) 1990-04-27 1992-06-21 Byk Gulden Lomberg Chem Fab Pyridazine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
WO1992006979A1 (de) 1990-10-15 1992-04-30 Byk Gulden Lomberg Chemische Fabrik Gmbh Neue diazine
JPH07500329A (ja) 1991-10-25 1995-01-12 ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング ピロロ−ピリダジン
CZ283216B6 (cs) * 1994-01-19 1998-02-18 Sankyo, Company Limited Pyrrolopyridazinové deriváty

Also Published As

Publication number Publication date
EP1186607A1 (en) 2002-03-13
US20020156079A1 (en) 2002-10-24
HUP0201434A2 (en) 2002-08-28
MXPA01013011A (es) 2002-11-07
NZ516194A (en) 2003-03-28
PT1186607E (pt) 2003-08-29
CA2375848A1 (en) 2000-12-21
PL356479A1 (en) 2004-06-28
EP1186607A4 (en) 2002-07-03
US6670360B2 (en) 2003-12-30
CZ290935B6 (cs) 2002-11-13
HK1044341A1 (en) 2002-10-18
CN1370172A (zh) 2002-09-18
RU2222541C2 (ru) 2004-01-27
HUP0201434A3 (en) 2003-09-29
NO20016099L (no) 2002-02-07
HK1044341B (en) 2003-10-03
NO20016099D0 (no) 2001-12-14
CZ20014505A3 (cs) 2002-05-15
ES2198319T3 (es) 2004-02-01
IL147088A (en) 2006-12-31
ZA200110279B (en) 2003-05-28
BR0011666A (pt) 2002-03-19
IL147088A0 (en) 2002-08-14
DE60002860D1 (de) 2003-06-26
CN1170829C (zh) 2004-10-13
AU757611B2 (en) 2003-02-27
TWI287014B (en) 2007-09-21
EP1186607B1 (en) 2003-05-21
WO2000077003A1 (en) 2000-12-21
KR20020022703A (ko) 2002-03-27
KR100583663B1 (ko) 2006-05-26
AU5426900A (en) 2001-01-02
TR200103685T2 (tr) 2002-05-21
ATE240957T1 (de) 2003-06-15
DE60002860T2 (de) 2004-05-06

Similar Documents

Publication Publication Date Title
ATE180468T1 (de) Anthranilsäure derivate
LU91210I2 (fr) Emodepside & Praziquantel ainsi que leurs dérivés pharmaceutiqement acceptables (PROFENDER)
DK1104760T3 (da) Sulfamoylheteroarylpyrazolforbindelser som anti-inflammatoriske/analgetiske midler
EP1043317A4 (en) PYRIDAZINE DERIVATIVES AND MEDICINES CONTAINING THE SAME AS ACTIVE INGREDIENTS
ATE260255T1 (de) 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate
PT976748E (pt) Derivados de pirrolidina com actividade inibidora de fosfolipase a2
NO20014925D0 (no) Farmasöytiske forbindelser
DK1104759T3 (da) Heteroarylphenylpyrazolforbindelser som antiinflammatoriske/analgetiske midler
DK2000465T3 (da) Triazolonderivat
DK1186607T3 (da) Optisk aktive pyrrolopyridazinforbindelser
DK0882728T3 (da) 1-methylcarbapenemderivater
DE60002558D1 (de) Derivate der Phosphonsäure zur Inhibierung von Carboxypeptidase B
ATE504572T1 (de) Derivate von aromatische heterocyclen enthaltende integraseinhibitoren
AU8003594A (en) Quinolinecarboxylic acid derivative and salt thereof
ATE361925T1 (de) Pyrrolopyridazin-verbindungen
MXPA04000485A (es) Uso de acidos aril o heteroaril hidroxamicos de sulfonilo y derivados de los mismos como inhibidores de agrecanasa.
FI944207A0 (fi) Cyclohexane derivatives
EP0450232A3 (en) P-guanidino benzoic acid derivatives for treatment of cerebrovascular contraction